Skip to main content

Table 2 HLA class-I alleles of the patients with cervical cancer and their tumor characteristics.

From: Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid

Patient

Diagnostic

Clinical stage (*)

HLA class-I haplotype

HPV type

1

SCC

IIIB

A2, B53, Cw4

A68, B48, Cw3

16

2

SCC

IB1

A2, B39, Cw3

A2, B60, Cw3

16

3

SCC

IIA

A2, B38(16), Cw3

A2, B60(40), Cw3

18

4

SCC

IIIB

A2, B35, Cw4

A3, B41, Cw7

18

  1. (*) FIGO clinical staging system.